Cannabis Testing Market Report 2026

The cannabis testing market size has grown rapidly in recent years. It will grow from $3.56 billion in 2025 to $4.26 billion in 2026 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to expansion of legalized cannabis markets, increasing regulatory safety requirements, growth of commercial cannabis production, adoption of laboratory-based quality testing, rising need for consumer safety assurance.

The cannabis testing market size is expected to see rapid growth in the next few years. It will grow to $8.72 billion in 2030 at a compound annual growth rate (CAGR) of 19.6%. The growth in the forecast period can be attributed to increasing investments in rapid testing technologies, rising demand for real-time potency analysis, expansion of standardized testing regulations, growing adoption of handheld testing devices, increasing integration of digital lab management systems. Major trends in the forecast period include increasing demand for comprehensive cannabis testing services, rising adoption of advanced chromatography techniques, growing focus on regulatory compliance testing, expansion of portable testing devices, enhanced data accuracy and traceability.

The rising prevalence of neurological conditions is anticipated to drive the growth of the cannabis testing market in the coming years. Neurological conditions are disorders that impact the nervous system, including the brain, spinal cord, and peripheral nerves, resulting in a range of cognitive, motor, and sensory impairments. Cannabis testing is employed in neurological conditions to analyze cannabinoids and investigate potential therapeutic benefits and effects on symptoms such as pain, spasticity, and seizures. For example, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population currently experienced some form of neurological condition, with this burden expected to nearly double by 2050. Consequently, the growing prevalence of neurological conditions is fueling the cannabis testing market.

Key players in the cannabis testing market are concentrating on developing innovative tests, including roadside cannabis tests, to meet the demand for precise impairment assessment and secure a competitive position in the market. A roadside cannabis test is a diagnostic approach that uses neurodiagnostics to evaluate recent cannabis use and related impairment. For instance, in April 2023, Oculogica, a US-based medical device company, introduced OcuPro, a roadside cannabis test that applies neurodiagnostics to assess recent cannabis consumption and associated impairment. The device, piloted across multiple Missouri police departments, captures and analyzes eye-pupil characteristics, distinguishing between use within the last 60-90 minutes and use occurring over several hours. Unlike traditional tests that rely on THC analysis from biological samples, OcuPro directly addresses the need for a scientifically validated method to detect impairment from recent cannabis use, which is vital for enforcing laws against driving under the influence.

In May 2023, ACT Laboratories, a US-based cannabis and hemp testing network, acquired Green Scientific Labs for an undisclosed amount. This acquisition was intended to diversify and expand its ready-to-drink (RTD) product portfolio. Green Scientific Labs is a US-based laboratory specializing in hemp, cannabis, and marijuana testing.

Major companies operating in the cannabis testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, SGS Canada Inc., Eurofins Scientific SE, Agilent Technologies Inc., Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, AB Sciex LLC, LGC Limited, Tentamus Group, Phenomenex Inc., Saskatchewan Research Council (SRC), Restek Corporation, SC Laboratories, Anresco Labs, Praxis Labs, Accelerated Technology Laboratories Inc., GreenLeaf Lab, ACT Laboratories, PharmLabs LLC, Abko Labs, BelCosta Labs, Medicinal Genomics, CW Analytical Laboratories Inc., DigiPath Inc., CDX Analytics, Steep Hill Halent Laboratories Inc.

North America was the largest region in the cannabis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cannabis testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cannabis testing market by increasing costs of imported analytical instruments, chromatography systems, spectrometers, reagents, and laboratory automation equipment. Testing laboratories in North America and Europe are most affected due to reliance on advanced imported technologies, while Asia-Pacific faces higher equipment procurement costs for export-oriented testing services. These tariffs are raising operational expenses and testing service prices. However, they are also encouraging local manufacturing of analytical instruments, regional laboratory expansion, and innovation in cost-efficient cannabis testing solutions.

The cannabis testing market research report is one of a series of new reports that provides cannabis testing market statistics, including cannabis testing industry global market size, regional shares, competitors with a cannabis testing market share, detailed cannabis testing market segments, market trends and opportunities, and any further data you may need to thrive in the cannabis testing industry. This cannabis testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cannabis refers to the analysis of a cannabis sample that is examined to determine levels of tetrahydrocannabinol, cannabidiol, and terpenes, as well as impurities such as residual solvents, mold, pests, disease, or pesticide residue. Cannabis testing is used to help relieve stress, muscle pain, nausea, and vomiting.

The main types of cannabis tests include potency testing, pesticide screening, residual solvent screening, heavy metal testing, terpene testing, mycotoxin testing, and others. Instruments refer to the tools used to test cannabis products. The different technologies include chromatography, spectroscopy, and others, and they come in various portability types, such as stand-alone and handheld devices. These instruments are used in testing laboratories, drug manufacturers, research institutes, and other end users.

The cannabis testing market includes revenues earned by entities by cannabinoid profile & potency analysis, heavy metal screening, mycotoxin screening, molds & mildews, pesticides & herbicides and residual solvents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.